Maria Concetta Fargnoli, MD of University of L’Aquila, L’Aquila, Italy, discusses genetic testing for skin cancer in clinical practice. First,…
Jeffrey Weber, MD, PhD of the NYU Langone Medical Center, New York, NY, discusses his introductory plenary lecture on the…
Jean-Jacques Grob, MD of the Aix-Marseille University and APHM Hospital CHU Timone, Marseille, France, gives an overview of his talk…
Ichiro Okamoto, MD of the Medical University of Vienna, Vienna, Austria discusses future challenges for genetic testing for skin cancer.…
Gerold Schuler, MD of University Hospital Erlangen, Erlangen, Germany discussed the field of biomarkers in melanoma at the 2016 World…
Clemens Krepler, MD of the Wistar Institute, Philadelphia, PA, provides an insight into the research on brain metastases in melanoma.…
Jean-Jacques Grob, MD of the Aix-Marseille University and APHM Hospital CHU Timone, Marseille, France, discusses the latest updates from ASCO…
Grant McArthur, MBBS, BMedSci, PhD, FRACP, of the Peter MacCallum Cancer Centre, Melbourne, Australia, discusses the ways genetic testing is…
Giovanni Pellacani, MD of the University of Modena and Reggio Emilia, Modena, Italy, discusses his talk on imaging techniques in…
Gerold Schuler, MD of University Hospital Erlangen, Erlangen, Germany explains how attitudes have changed towards the use of cancer vaccines…
Eva Lehner-Baumgartner, PhD of Vienna General Hospital, Vienna, Austria, speaks about the role of clinical psychologists and therapists in patient…
Clemens Krepler, MD of the Wistar Institute, Philadelphia, PA, discusses the developments of the research on mouse models for melanoma.…
Is there a role for immunotherapy for multiple myeloma (MM) patients? Using an analogy of waking the blood hounds, Patient…
Axel Hauschild, MD, PhD of the University Hospital Schleswig-Holstein, Kiel, Germany, discusses the exciting new data on Merkel cell carcinoma…
Dr. Nima Sharifi, MD gives his expert opinion on a collaborative Cleveland Clinic-Mayo Clinic team of researchers that has shown…
Dr. Nima Sharifi, MD reviews the data from a collaborative Cleveland Clinic-Mayo Clinic team of researchers has shown for the…
The results of a collaborative Cleveland Clinic-Mayo Clinic team of researchers has shown for the first time that patients with…
Dr. Nima Sharifi, MD of the Cleveland Clinic gives a brief background to a collaborative Cleveland Clinic-Mayo Clinic study. A…
Beate Lichtenberger, PhD of the Medical University of Vienna, Vienna, Austria, discusses her highlights from the 2016 World Congress on…
Nikolas Haass, MD, PhD of the University of Queensland, Brisbane, Australia discusses the work of his lab on dynamic heterogeneity…
Axel Hauschild, MD, PhD of University Hospital Schleswig-Holstein, Kiel, Germany, discusses the evaluation of long-term survival and prognostic subgroups of…
Marius Erik Mayerhöfer, MD, PhD of the Medical University of Vienna, Vienna, Austria gives an overview of his talk on…
Petr Arenberger, MD, PhD, DSc, MBA of Charles University, Prague, Czech Republic discusses the Anti-Melanoma Tent initative, where experts travel…
Gerold Schuler, MD of University Hospital Erlangen, Erlangen, Germany discusses cancer vaccines and in particular, the potential to develop a…
Eva Lehner-Baumgartner, PhD of Vienna General Hospital, Vienna, Austria, talks about the importance of doctors providing patients with information. Regardless…
Dirk Schadendorf, MD of University Hospital Essen, Essen, Germany discusses the results of the efficacy and quality of life outcomes…
Clemens Krepler, MD of the Wistar Institute, Philadelphia, PA, discusses resistance mechanisms in BRAF-mutated melanoma in mouse models. The tumors…
Axel Hauschild, MD, PhD of University Hospital Schleswig-Holstein, Kiel, Germany, gives an overview of his talk on the future of…
Brigitte Dréno, MD, PhD of the University Hospital of Nantes, Nantes, France discusses vaccinations for melanoma and the decrease in…
Beate Lichtenberger, PhD of the Medical University of Vienna, Vienna, Austria, provides an insight into the new research that is…
Axel Hauschild, MD, PhD of University Hospital Schleswig-Holstein, Kiel, Germany, gives an overview of his talk on vemurafenib and cobimetinib…
Petr Arenberger, MD, PhD, DSc, MBA of Charles University, Prague, Czech Republic discusses skin cancer in Central Europe at the…
Nikolas Haass, MD, PhD of the University of Queensland, Brisbane, Australia discusses cell cycle-dependent drug resistance or sensitivity in melanoma.…
Marius Erik Mayerhöfer, MD, PhD of the Medical University of Vienna, Vienna, Austria discusses changes in the imaging methods used…
Herbert Hönigsmann, MD of the Medical University of Vienna, Vienna, Austria discusses issues in the use of sun protection by…
Isaac Brownell, MD, PhD of the National Cancer Institute, Bethesda, MD gives an overview of his talk on new treatment…
Herbert Hönigsmann, MD of the Medical University of Vienna, Vienna, Austria outlines his talk sun protection held at the World…
Gerold Schuler, MD of University Hospital Erlangen, Erlangen, Germany discusses his talk on vaccines for melanoma held at the 2016…
Eva Lehner-Baumgartner, PhD, of the Medical University of Vienna, Vienna, gives an overview of her talk on strategies to support…
Dirk Schadendorf, MD of University Hospital Essen, Essen, Germany gives an overview of his talk on kinase inhibitors in rare…
Clemens Krepler, MD of the Wistar Institute, Philadelphia, PA, discusses his work on BRAF inhibition in melanoma. 50% of melanomas…
Beate Lichtenberger, PhD of the Medical University of Vienna, Vienna, Austria, discusses the role of fibroblasts in cutaneous carcionogenesis. Dr…
Axel Hauschild, MD, PhD of University Hospital Schleswig-Holstein, Kiel, Germany, gives an overview of his talk on dabrafenib and trametinib…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Marcello Deraco discusses the treatment of surgically-resectable…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Harpreet Wasan argues that radio- or chemoembolization…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Phillipe Rouanet discusses whether or not robotic…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Heinz-Josef Lenz discusses whether tumor location is…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Aimery de Gramont discusses how to improve…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Takayuki Yoshino presents Asian guidelines for the…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Axel Grothey presents the NCCN guidelines for…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Eric Van Cutsem discusses the ESMO guidelines…
In this Keynote Lecture, Dr. Paul Cornes discusses health economics and cost from both the physician’s and payer’s perspective, with…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Roberto Labianca presents highlights of the poster…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Ramon Salazar examines whether gene signatures are…
How to improve the diagnosis of stage III colon cancer?
This video is the study background of a collaborative Cleveland Clinic-Mayo Clinic team of researchers has shown for the first…
What does MPN (myeloproliferative neoplasm) mean? How has the MPN field changed in recent years? Patient Power Host and MPN…
Are stem cell transplants an effective treatment for patients with multiple myeloma (MM)? Myeloma expert Dr. Gareth Morgan of UAMS…
According to a new study, African-American women who participate in vigorous exercise had a 12% lower risk of receiving a…
Dr. Andrei Gudkov, Senior Vice President for Basic Science at Roswell Park Cancer Institute in Buffalo, NY shares findings from…
New research, co-authored by James Mohler, MD, Chair of the Department of Urology at Roswell Park Cancer Institute, reveals that…
David Hui, MD, MSc of MD Anderson Cancer Center, Houston, TX discusses end-of-life decisions, which should be based on patients…
David Hui, MD, MSc of MD Anderson Cancer Center, Houston, TX discusses hydration and nutrition in end-of-life patients. Hydration is…
In this Keynote Lecture, Dr. Scott Kopetz discusses the BRAF pathway in colorectal cancer (CRC).
In this Keynote Lecture, Dr. Aurélien Marabelle discusses the relevant immune mechanisms in GI cancer.
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Drs. Andrés Cervantes and Karin Haustermans examine two…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Julio Garcia-Aguilar discusses the advances and challenges…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Andre D’Hoore discusses how to best to…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Gina Brown argues that MRI is mandatory…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Monique Van Leerdam discusses the image of…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Nadir Arber discusses whether or not advanced…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Judith Balmaña discusses hereditary colon and gastric…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Eric Raymond discusses new targets and agents…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Chris Verslype arguest for the locoregional treatment…
Developing a therapeutic algorithm in small bowel NETs
Charles Loprinzi, MD of Mayo Clinic, Rochester, MN discusses the use of olanzapine for nausea control in chemotherapy-treated patients. Data…
How do you choose the best treatment options for YOUR multiple myeloma (MM)? With more multiple myeloma treatments being approved…
Charles Loprinzi, MD of Mayo Clinic, Rochester, MN discusses treatment options for patients with established neuropathy. If a chemotherapy treatment…
Merran Findlay, AdvAPD of The University of Sydney, Sydney, Australia, discusses her view on patient nutrition during early stages of…
Charles Loprinzi, MD of Mayo Clinic, Rochester, MN gives an overview of neuropathy risk factors and discusses new data showing…
Merran Findlay, AdvAPD of The University of Sydney, Sydney, Australia, explains that a diagnosis of head and neck cancer typically…
Gregory Crawford, MBBS, MPHC, MD, FRACGP, FAChPM of The University of Adelaide, Adelaide, Australia discusses the importance of understanding patients…
Merran Findlay, AdvAPD of The University of Sydney, Sydney, Australia, discusses patient care and access to specialist dietitians. Specialist dietitians…
Jervoise Andreyev, MA, PhD, FRCP of The Royal Marsden NHS Foundation Trust, London, United Kingdom discusses the need for a…
Merran Findlay, AdvAPD of The University of Sydney, Sydney, Australia, discusses clinical guidelines and available literature on patient care from…
James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK, discusses the highlights in melanoma from the…
James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK, discusses aggressive melanoma, which he considers to…
Sharon Liberali, BDS (Adel), DClinDent (FICD, FPFA, FRACDS) of Adelaide Dental Hospital, Adelaide, Australia, discusses the role of dentist in…
Sharon Liberali, BDS (Adel), DClinDent (FICD, FPFA, FRACDS) of Adelaide Dental Hospital, Adelaide, Australia, emphasizes the importance of the treatment…
Gregory Crawford, MBBS, MPHC, MD, FRACGP, FAChPM of The University of Adelaide, Adelaide, Australia discusses a session organised by the…
James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK, discusses the session Clinical problems in oncology…
Karen Mustian, PhD, MPH, ACSM of the University of Rochester Medical Center, Rochester, New York, NY gives a brief overview…
James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK, explains the treatment options available for patients…
Thomas Powles, MD, PhD from Barts Cancer Institute, London, UK discusses the BISCAY clinical trial in bladder cancer (NCT02546661). The…
Martin Reck, MD, PhD of the LungenClinic Grosshansdorf, Grosshansdorf, Germany, highlights the importance of the randomized Phase III JAVELIN Lung…
James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK, discusses the upcoming Melanoma Patient Conference in…
Eleni Efstathiou, MD, PhD of the University of Texas MD Anderson Cancer Center, Houston, Texas, TX, provides an overview of…
Anas Younes, MD of Memorial Sloan Kettering Cancer Center, New York, NY talks about how social media can give you…
Anas Younes, MD of Memorial Sloan Kettering Cancer Center, New York, NY talks about the iwNHL 2016 meeting that will…
Karen Mustian, PhD, MPH, ACSM of the University of Rochester Medical Center, Rochester, New York, NY, discusses various fatigue dimensions…
Sharon Liberali, BDS (Adel), DClinDent (FICD, FPFA, FRACDS) of Adelaide Dental Hospital, Adelaide, Australia, emphasises the importance of dentists during…
Charles Loprinzi, MD from Mayo Clinic, Rochester, MN discusses neurotoxicities caused by a chemotherapy treatment. Numbness, tingling, shooting, and burning…
Karen Mustian, PhD, MPH, ACSM of the University of Rochester Medical Center, Rochester, New York, NY, discusses advantages of using…
Karen Mustian, PhD, MPH, ACSM of the University of Rochester Medical Center, Rochester, New York, NY, discusses the importance of…
Mark Schubert, DDS, MSD of Seattle Care Alliance, Seattle, WA provides an overview of his journey through plasmacytoma treatment. With…
Rachel Gibson, PhD of University of South Australia, Adelaide, Australia highlights the 25th anniversary of MASCC in Adelaide, Australia. MASCC…
Mark Schubert, DDS, MSD of Seattle Care Alliance Seattle, WA discusses what he as a dental clinician has learnt through…
Dr. Luke Peppone of University of Rochester Medical Center, Rochester, NY discusses results from a preliminary study measuring omega 3…
Rachel Gibson, PhD of University of South Australia, Adelaide, Australia explores the links between chemotherapy induced toxicities that would normally…
In this Ask the Expert segment, Dr. Gareth Morgan of UAMS Myeloma Institute answers a question from Patient Power viewer,…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Bertram Wiedenmann discusses the clinician’s contribution to…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Christophe Deroose discusses the contribution of isotopic…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Timm Denecke discusses the contribution of CT…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Florian Lordick discusses new agents on the…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Andrés Cervantes discusses the impact of targeting…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. William H. Allum provides the surgeon’s perspective…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. March Ychou provides the EU perspective on…
In this Keynote Lecture, Dr. Adam Bass examines the taxonomy in gastric cancer.
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Fátima Carneiro discusses the pathologist’s perspective on…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. David H. Ilson examines which is the…
Thomas Powles, MD, PhD from Barts Cancer Institute, London, UK discusses key points of a new Phase III clinical trial…
Sumanta Pal, MD of City of Hope, Duarte, CA, discusses the introduction of new data of the new single-agent cabozantinib…
Press brief by Philip Mack, PhD of the UC Davis Comprehensive Cancer Center, Sacramento, CA, at the 2016 Annual Meeting…
Paolo Ascierto, MD, of the National Tumor Institute Fondazione G. Pascale, Naples, Italy, discusses the safety of nivolumab for advanced…
James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK, discusses the next steps for the treatment…
Erika Hamilton of Sarah Cannon Research Institute, Nashville, TN talks about a Phase I trial of ONT-380 in combination with…
David Ross Camidge, MD, PhD of the University of Colorado, Denver, CO, provides an insight into emibetuzumab, a monoclonal antibody…
What is phlebotomy, and how will it help my polycythemia vera (PV)? Patient Power Founder and Host, Andrew Schorr,, discusses…
What is the role of transplant in treatment of multiple myeloma? From our town meeting in Little Rock, Arkansas, in…
What are the benefits to participating in multiple myeloma clinical trials? Dr. Faith Davies of UAMS Myeloma Institute responds to…
Will my essential thrombocythemia (ET) or polycythemia vera (PV) progress to myelofibrosis (MF)? Patient Power host and MF patient, Andrew…
Toni Choueiri, MD of the Dana-Farber Cancer Center, Boston, MA discusses the Phase III METEOR randomized clinical trial of cabozantinib…
Neal Shore, MD of the Carolina Urologic Research Center, Myrtle Beach, SC, discusses the advances in the development of treatments…
Paolo Ascierto, MD, of the National Tumor Institute Fondazione G. Pascale, Naples, Italy, discusses the Phase II safety study CheckMate…
Jonathan Ledermann, MD, FRCP from University College London, London, UK discusses his presentation on the update on the results of…
Hendrik-Tobias Arkenau, MD, PhD from the Sarah Cannon Research Institute, London, UK discusses his highlights from the American Society of…
David Ross Camidge, MD, PhD of the University of Colorado, Denver, CO, provides an insight into the study (NCT01631552) of…
James Larkin, MD, PhD, of the Royal Marsden NHS Foundation Trust, London, UK discusses the use of the new immunotherapy…
Sumanta Pal, MD of City of Hope, Duarte, CA, discusses the BGJ398 clinical trial in patients with previously treated advanced/metastatic…
Erika Hamilton of Sarah Cannon Research Institute, Nashville, TN talks about the Phase I trial of AZD2014 for the treatment…
Bristol-Myers Squibb Company announced that CheckMate 026, a trial investigating the use of Opdivo or nivolumab as monotherapy, did not…
Jalid Sehouli, MD, PhD from Charité Comprehensive Cancer Center, Berlin, Germany discusses the Phase II TRIAS 2009 trial of sorafenib…
Grant McArthur, MBBS, BMedSci, PhD, FRACP from the Peter MacCallum Cancer Centre, Melbourne, Australia gives an overview of mutations in…
Grant McArthur, MBBS, BMedSci, PhD, FRACP from the Peter MacCallum Cancer Centre, Melbourne, Australia discusses the results of the Phase…
Gary K. Schwartz, MD of the Columbia University Medical Center, New York, NY discusses the success and potential of immunology…
Manmeet Ahluwalia, MD of the Cleveland Clinic Cancer Center discusses how ANG1005 shows promise for patients with leptomenigeal disease
Manmeet Ahluwalia, MD from Cleveland Clinic Cancer Center and the Predictive and Prognostic biomarkers for Brain Metastasis
Manmeet Ahluwalia, MD of Cleveland Clinic Cancer Center discusses the side effect profile of ANG1005 from ASCO 2016
Manmeet Ahluwalia, MD of Cleveland Clinic Cancer Center outlines how ANG1005 shows promise in Brain Cancer at ASCO 2016
Manmeet Ahluwalia, MD of Cleveland Clinic Cancer Center discusses Blood Brain Barrier and TKI in Brain Cancer treatment at ASCO…
Manmeet Ahluwalia, MD of Cleveland Clinic Cancer Center discusses Treating Brain Metastasis is being redefined due to genomic profiling from…
Jame Abraham, MD discusses PD-L1 in Triple Negative Breast Cancer from ASCO 2016
Jame Abraham, MD @CleClinicMD Cleveland Clinic Cancer Center highlights the Current and future Immunotherapy outlook in breast cancer from ASCO…
Dr. Jame Abraham, MD of the Cleveland Clinic Cancer Center @CleClinicMD discusses the PALOMA trials summary and Palbociclib in ER-positive…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. George Hanna discusses which esophageal cancer patients…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. David Cunningham discusses which esophageal cancer patients…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Margaret A. Tempero discusses new agents and…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Massimo Falconi examines whether or not we…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Thomas Seufferlein argues that it is not…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Jordan D. Berlin argues that it is…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Pascal Hammel discusses screening in familial pancreatic…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Dileep Lobo examines whether peri-operative nutritional support…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Florian Strasser discusses cachexia and sarcopenia in…
In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Jens Ricke discusses the pitfalls in imaging…
Giuseppe Saglio, MD of the University of Turin, Turin, Italy discusses the back and forth between basic research and clinical…
Giuseppe Saglio, MD of the University of Turin, Turin, Italy provides an overview of the results of the Phase III…
Gail Roboz, MD from Weill Medical College of Cornell University, New York, NY discusses new treatments for elderly acute myeloid…
Nearly 12% of men with advanced prostate cancer have inherited mutations in genes that play a role in repairing damaged…
Thomas Powles, MD, PhD from Barts Cancer Institute, London, UK discusses the BISCAY clinical trial in bladder cancer (NCT02546661). The…
Philippe Rousselot, MD, PhD from Versailles Hospital and University, Versailles, France discusses the current medical need of Philadelphia chromosome-positive (Ph+)…
Thomas Powles, MD, PhD from Barts Cancer Institute, London, UK discusses a talk on immune checkpoint inhibitors in bladder cancer…
Joseph Mikhael, MD from the Mayo Clinic, Scottsdale, AZ discusses his highlights for multiple myeloma (MM) from the American Society…
Anton Hagenbeek, MD, PhD from University of Amsterdam, Netherlands provides a summary of the press briefings held at the European…
John Pagel, MD, PhD of the Swedish Cancer Institute, Seattle, WA discusses highlights for chronic lymphocytic leukemia (CLL) from the…
John Pagel, MD, PhD of the Swedish Cancer Institute, Seattle, WA provides an overview of an educational session on the…
Finbarr Cotter, MD, PhD from British Society of Hematology (BSH) Conferences and Barts Health NHS Trust, UK discussing the 2016…
Andrew Zelenetz, MD, PhD, from Memorial Sloan-Kettering Cancer Center, New York, NY discusses the mechanism of action of ibrutinib and…
Susan O’Brien, MD from the University of California, Irvine, CA discusses Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) and the…
Rafael Fonseca, MD from the Mayo Clinic, Scottsdale, AZ discusses the importance of monoclonal antibodies for multiple myeloma (MM). At…
Press brief by Katherine A High, MD of the The Children’s Hospital of Philadelphia, at the 2016 Annual Meeting of…
Press brief by Johan Richter, MD, PhD of the SkÃ¥ne University Hospital Lund, Lund, Sweden, at the 2016 Annual Meeting…
Philippe Rousselot, MD, PhD from Versailles Hospital and University, Versailles, France discusses the concern of molecular relapse in chronic myeloid…
Emili Montserrat, MD, PhD from the University of Barcelona, Barcelona, Spain discusses the goals and work of the European Research…
Georg Lenz, MD, PhD, from the University of Münster, Münster, Germany discusses the clinical significance of diagnosing diffuse large B-cell…
Katja Weisel, MD from University Hospital Tuebingen, Tuebingen, Germany gives an overview of the current situation for multiple myeloma patients…
Philippe Rousselot, MD, PhD from Versailles Hospital and University, Versailles, France, discusses the use of blinatumomab in patients with acute…
Stephan Grupp, MD, PhD from Children’s Hospital of Philadelphia, Philadelphia, PA discusses his research into pediatric acute lymphoid leukemia (ALL).…
Michael Hallek, MD from the University of Cologne, Cologne, Germany discusses the potential benefits of biosimilars. Prof. Hallek suggests that…
Philippe Rousselot, MD, PhD from Versailles Hospital and University, Versailles, France, discusses the role of inotuzumab ozogamicin, which is currently…
Emili Montserrat, MD, PhD from the University of Barcelona, Barcelona, Spain discusses the best treatment advice for patients with chronic…
Emili Montserrat, MD, PhD from the University of Barcelona, Barcelona, Spain discusses the issue of drug cost in chronic lymphocytic…
Emili Montserrat, MD, PhD from the University of Barcelona, Barcelona, Spain discusses the influence of the European Research Initiative on…
For decades, the hallmark of medical treatment for cancer and hematological malignancies has been intravenous cytotoxic chemotherapy. These drugs target…
Stephan Grupp, MD, PhD from Children’s Hospital of Philadelphia, Philadelphia, PA outlines his work at the University of Pennsylvania. Currently…
The National Cancer Act signed in 1971 officially started what is commonly referred to as the war against cancer. Since…
Peter Hillmen, MBChb, PhD, FRCP, FRCPath from St. James’ University Hospital, Leeds, UK discusses the use of the word ‘cure’…
Peter Hillmen, MBChb, PhD, FRCP, FRCPath from St. James’ University Hospital, Leeds, UK discusses allogeneic stem cell transplantation for chronic…
Michele Baccarani, MD from University of Bologna, Bologna, Italy, discusses the symposium on Current and emerging treatment goals in chronic…
Georg Lenz from the University of Münster, Münster, Germany discusses the current unmet need in diffuse large B-cell lymphoma (DLBCL),…
Georg Lenz from the University of Münster, Münster, Germany discusses diffuse large B-cell lymphoma (DLBCL) at the European Hematology Association…
Haifa Kathrin Al-Ali, MD from the University of Leipzig, Leipzig, Germany discusses what can be done for myelofibrosis patients who…
Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD from Oxford University Hospitals NHS Foundation Trust, Oxford, UK discusses the next steps that…
Gail Roboz, MD from Weill Medical College of Cornell University, New York, NY discusses the standardization of flow cytometry in…
Giuseppe Saglio, MD of the University of Turin, Turin, Italy discusses the pros and cons of chronic myeloid leukemia (CML)…
Mark Caulfield, MD from the Genomics England and Queen Mary University, London, UK discusses aspects on the UK hematology community.…
Finbarr Cotter, MD, PhD from British Society of Hematology (BSH) Conferences and Barts Health NHS Trust, UK discusses some of…
Peter Hillmen, MBChb, PhD, FRCP, FRCPath from St. James’ University Hospital, Leeds, UK talks about current clinical trials in chronic…
Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD from Oxford University Hospitals NHS Foundation Trust, Oxford, UK discusses the different forms of multiple…
Dr. James Pellicane discusses the advantages of using the BioZorb implant during breast cancer surgery. By clearly identifying the surgical…
Dr. Stephen Harms, a breast imaging expert at Medical Associates of Northwest Arkansas, reports that the BioZorb device is easily…
Dr. Jennifer Gass, Chief of Surgery at Women & Infants Hospital of Rhode Island, describes how the 3D BioZorb device…
The BioZorb marker is valuable in oncoplastic breast reduction procedures during breast cancer surgery, according to MedStar Georgetown University Hospital…
V. Suzane Klimberg, MD, FACS, explains how the BioZorb implant satisfies an unmet need for breast surgeons and patients by…
Jason A. Zell, DO, MPH Associate Professor, Depts. Of Medicine & Epidemiology School of Medicine University of California, Irvine discusses…
Ignatius Ou, MD PhD UC Irvine School of Medicine discusses recently released data from ASCO 2016 about lung cancer
Chaitali Nangia, MD of UC Irvine Health presents Breast Cancer updates 2016 which includes data recently released from ASCO 2016
Samuel J. Klempner, MD Director of Precision Medicine The Angeles Clinic and Research Institute goes over the new data from…
Kanwar Kahlon, MD Assistant Clinical Professor, Department of Medicine UC Irvine discusses ASCO 2016 data concerning the treatment of Multiple…
John Fruehauf, MD, phd Director Clinical pharmacology and developmental therapeutics UCI Irvine Comprehensive cancer center goes over the best data…
Dr. Eddie Mendez discusses novel treatments in head and neck cancers at Seattle Cancer Care Alliance, particularly in immunotherapy, robotic…
The state-of-the-art MRgRT suite at the Princess Margaret Cancer Centre combines the best of medical imaging with radiation therapy to…
How can patients best manage side effects for better quality of life? Andrew Schorr, facilitates a dialogue between advanced prostate…
AACR brought young investigators to Capitol Hill to explain the importance for continued momentum for ample funding for cancer support.…
Owen O’Connor, MD, PhD from Columbia University Medical Center, New York, NY discusses the positive trend in the research for…
Michael Hallek, MD from the University of Cologne, Cologne, Germany gives an overview of the German CLL Study Group (GCLLSG),…
Michael Hallek, MD from the University of Cologne, Cologne, Germany talks about the issue of drug cost in oncology. According…
Davide Rossi, MD, PhD from University of Eastern Piedmont, Vercelli, Italy discusses the unmet needs of chronic lymphocytic leukemia (CLL)…
Matthew Davids, MD from Dana-Farber Cancer Institute, Boston, MA outlines the differences in the treatment of older and younger patients.…
Owen O’Connor, MD, PhD from Columbia University Medical Center, New York, NY discusses his colleague Dr George Tangs investigation into…
Matthew Davids, MD from Dana-Farber Cancer Institute, Boston, MA outlines the poster demonstrating preliminary results from an investigator initiated study…
Owen O’Connor, MD, PhD from Columbia University Medical Center, New York, NY outlines his presentation on the updates from the…
Davide Rossi, MD, PhD from University of Eastern Piedmont, Vercelli, Italy outlines the novel treatment options for chronic lymphocytic leukemia…
Matthew Davids, MD, from Dana-Farber Cancer Institute, Boston, MA outlines the importance of being aware of a patient’s tumor lysis…
Matthew Davids, MD from Dana-Farber Cancer Institute, Boston, MA outlines the poster demonstrating the safety analysis of venetoclax, BCL-2 inhibitor,…
Anton Hagenbeek, MD, PhD from the University of Amsterdam, Amsterdam, Netherlands discusses how he hopes the treatment of cancer will…
Anton Hagenbeek, MD, PhD from the University of Amsterdam, Amsterdam, Netherlands talks about the issue of drug costs in oncology.…
Anton Hagenbeek, MD, PhD from the University of Amsterdam, Amsterdam, Netherlands discusses how he hopes the treatment of cancer will…
Immunotherapy is a groundbreaking therapy for solid tumors. Where are we with using immunotherapy to treat multiple myeloma? Myeloma expert…
Should patients consider participating in a clinical trial? Andrew Schorr, Patient Power founder and host, leads a discussion with advanced…
Should patients consider participating in a clinical trial? Andrew Schorr, Patient Power founder and host, leads a discussion with advanced…
Eduardo Rego, MD, PhD from University of São Paulo, Brazil discusses coagulopathy in acute myeloid leukemia (AML) at the European…
Eduardo Rego, MD, PhD from University of São Paulo, Brazil discusses the main challenges, primarily bleeding, practitioners face when treating…
Eduardo Rego, MD, PhD from University of São Paulo, Brazil outlines his presentation on his experience with networking as a…
Eduardo Rego, MD, PhD from University of São Paulo, Brazil outlines his presentation on his experience with networking as a…
Barbara Eichhorst, MD from University of Cologne, Cologne, Germany outlines the format of the annual workshop of the German CLL…
Jean-Jacques Kiladjian, MD, PhD from Saint-Louis Hospital & Paris Diderot University, Paris, France discusses the impact of patients registries on…
Jean-Jacques Kiladjian, MD, PhD from Saint-Louis Hospital & Paris Diderot University, Paris, France discusses a selection of topics covered during…